News AroCell AB

Equities

Delayed Nasdaq Stockholm Other stock markets 01:23:38 15/05/2024 pm IST			5-day change	1st Jan Change
0.4 ^SEK	-4.31%		-10.11%	-8.47%

03/05	AroCell AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
18/04	Swedish Diagnostics Company AroCell Secures US Patent	MT

AroCell AB (publ) Interim Report January 1st to March 31st, 2024	06/05	AQ
AroCell Q1 - Unrecognized and going well	06/05	AQ
AroCell AB (publ) Interim Report January 1st to March 31st, 2024	03/05	AQ
AroCell AB Reports Earnings Results for the First Quarter Ended March 31, 2024	03/05	CI
AroCell - New patent approved on the US market	19/04	AQ
Swedish Diagnostics Company AroCell Secures US Patent	18/04	MT
New patent approved on the US market	18/04	AQ
AroCell Attends Three Prestigious Events: AACR, EAU Congress and COG Nordics	16/04	PU
AroCell publishes the Annual Report for 2023	15/04	AQ
AroCell publishes the Annual Report for 2023	12/04	AQ
The nomination committee's proposal for the board of AroCell for the Annual General Meeting 2024	12/03	AQ
New Study: UBC Rapid can reduce the number of cystoscopies necessary in bladder cancer patients, enabling cost-effective follow-up	12/03	AQ
Two Accepted Abstracts at AACR 2024 Explore Clinical Applications of TK1 Biomarker	11/03	AQ
AroCell : Presentation at LabRoots 2024	04/03	PU
AroCell Q4 - Nearing positive operating cash flow	23/02	AQ
AroCell AB (publ) Interim Report January 1st to December 31st, 2023	22/02	AQ
AroCell AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02	CI
AroCell AB Reports Earnings Results for the Full Year Ended December 31, 2023	22/02	CI
AroCell Names CFO Goes on Parental Leave, Interim CFO Named	01/02	MT
Ellen Dittberner, AroCell's CFO, will be taking parental leave, and Lars Jakobsson will step in as the interim CFO.	01/02	AQ

No results for this search